Live Salesforce, Inc. Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow HYPERION DEFI, INC.

Get SEC filing alerts via email and in your feed for HYPERION DEFI, INC.

HYPD

HYPERION DEFI, INC.

About HYPERION DEFI, INC.

Eyenovia, Inc. develops innovative ophthalmic delivery platforms, primarily the Optejet, for precise microdosing of eye medications. Its core products include FDA-approved Mydcombi for pupil dilation and licensed clobetasol propionate for post-surgical inflammation. The company focuses on improving treatment efficacy, safety, and patient compliance through targeted, low-volume delivery systems, leveraging digital health integration and strategic licensing in ophthalmology markets.
This description was generated via AI from an annual report. Updated 8 months ago.

Latest SEC Filings from HYPERION DEFI, INC.

1
1
HYPERION DEFI, INC. Hyperion DeFi Reports Revenue Surge to $244,271 and Net Income of $8.8 Million

Via official filing (AI summary) | 19 days ago | 0 comments

2
1
HYPERION DEFI, INC. Hyperion DeFi Reports Revenue Surge to $813,455, Shifts Focus to Digital Assets

Via official filing (AI summary) | 2 months ago | 0 comments

3
1
HYPERION DEFI, INC. Hyperion DeFi Reports Revenue Surge to $302,506 and Net Income of $6.6 Million

Via official filing (AI summary) | 7 months ago | 0 comments

4
1
HYPERION DEFI, INC. Hyperion DeFi Reports No Revenue and $12.2 Million Net Loss for First Half of 2025

Via official filing (AI summary) | 10 months ago | 0 comments

5
1
HYPERION DEFI, INC. Eyenovia Reports Revenue Increase to $14,720 and Reduced Net Loss in Q1 2025

Via official filing (AI summary) | about 1 year ago | 0 comments

6
1
HYPERION DEFI, INC. Eyenovia Reports $49.8 Million Net Loss for 2024 Amidst Strategic Restructuring

Via official filing (AI summary) | about 1 year ago | 0 comments

7
1
HYPERION DEFI, INC. Eyenovia Reports Modest Revenue Growth, Substantial Net Losses in Q3 2024

Via official filing (AI summary) | over 1 year ago | 0 comments